Literature DB >> 18763428

Depression and sleep-related symptoms in an adult, indigenous, North American population.

Colleen L Froese1, Arsalan Butt, Alan Mulgrew, Rupi Cheema, Mary-Ann Speirs, Carmen Gosnell, Jon Fleming, John Fleetham, C Frank Ryan, Najib T Ayas.   

Abstract

STUDY
OBJECTIVES: Symptoms related to sleep disorders are common and may have substantial adverse impacts on mental health. Indigenous North Americans (American Indian) are a medically vulnerable population with reduced access to healthcare services. The purposes of this study were to assess (1) the prevalence of sleep symptoms and (2) the relationships between symptoms and depression in this population.
METHODS: We performed a community-based, door-to-door, cross-sectional survey of 3 indigenous North American groups (Gitxsan, Nisga'a and Tsimshian) living in the northwestern part of British Columbia. Between May and September of 2006, subjects completed a comprehensive questionnaire that included questions about sleep habits, medical history, subjective sleepiness (Epworth Sleepiness Scale), and depression (Personal Health Questionnaire [PHQ-9]). Weights and heights were also measured.
RESULTS: Four hundred thirty adults participated in the study (response rate = 42%). Their mean age was 43.2 years. Three hundred ninety-three agreed to have heights and weights measured. Their mean body mass index (BMI) was 31.0 +/- 9.2 kg/m2; 45% of them (177/393) were obese (BMI > 30 kg/m2), and 11% (43/393) were morbidly obese (BMI > 40 kg/m2). The prevalence of sleep complaints was high; insomnia symptoms was reported by 17.2%, symptoms of restless legs syndrome (RLS) by 17.7%, and frequent witnessed apneas reported (i.e., being told they stopped breathing at least 3 nights per week) by 7.6%. Of the 76 patients who had RLS symptoms, only 3 (3.9%) reported having received a diagnosis of RLS from a physician. Thirty-three subjects reported having frequent witnessed apneas, but only 5 of them (15.1%) reported having received a diagnosis of OSA from a physician. The mean PHQ9 score was 4.86 +/- 5.13 (reported by 389 subjects). Twenty-eight subjects (7.20%) had moderate to severe depression, with a PHQ-9 score of 15 or greater. In multivariable linear regression analysis, insomnia symptoms, witnessed apneas, and RLS symptoms were independently associated with an increase in PHQ9 score; frequent witnessed apneas were associated with an increase in PHQ9 by 2.46 (95% confidence interval: 0.47-4.46), insomnia symptoms by 4.49 (95% confidence interval: 3.14-5.83), and RLS symptoms by 1.82, (95% confidence interval: 0.53-3.12).
CONCLUSIONS: Sleep symptoms and depression are common in the indigenous North American population of northern British Columbia. Sleep-related symptoms (insomnia symptoms, witnessed nocturnal apneas, and RLS symptoms) are independently associated with depression scores. Improving access to sleep-related diagnostic and therapeutic services may substantially improve mental health in this vulnerable patient population.

Entities:  

Mesh:

Year:  2008        PMID: 18763428      PMCID: PMC2542493     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  26 in total

1.  Craniofacial profile in Asian and white subjects with obstructive sleep apnoea.

Authors:  B Lam; M S M Ip; E Tench; C F Ryan
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

2.  Differences in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia.

Authors:  Maria Victoria Monsalve; Harvey V Thommasen; George Pachev; Jiri Frohlich
Journal:  Med Sci Monit       Date:  2005-01

3.  Awareness of driving while sleepy and road traffic accidents: prospective study in GAZEL cohort.

Authors:  Hermann Nabi; Alice Guéguen; Mireille Chiron; Sylviane Lafont; Marie Zins; Emmanuel Lagarde
Journal:  BMJ       Date:  2006-06-23

4.  The Epworth Sleepiness Scale: influence of age, ethnicity, and socioeconomic deprivation. Epworth Sleepiness scores of adults in New Zealand.

Authors:  Philippa H Gander; Nathaniel S Marshall; Ricci Harris; Papaarangi Reid
Journal:  Sleep       Date:  2005-02       Impact factor: 5.849

Review 5.  Obesity, ethnicity, and sleep-disordered breathing: medical and health policy implications.

Authors:  Carolina Q See; Edward Mensah; Christopher O Olopade
Journal:  Clin Chest Med       Date:  2006-09       Impact factor: 2.878

6.  Obstructive sleep apnea as a risk factor for stroke and death.

Authors:  H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

7.  Longitudinal association of sleep-related breathing disorder and depression.

Authors:  Paul E Peppard; Mariana Szklo-Coxe; K Mae Hla; Terry Young
Journal:  Arch Intern Med       Date:  2006-09-18

Review 8.  Epidemiology of restless legs syndrome: the current status.

Authors:  Diego Garcia-Borreguero; Renata Egatz; Juliane Winkelmann; Klaus Berger
Journal:  Sleep Med Rev       Date:  2006-06       Impact factor: 11.609

9.  Who reports insomnia? Relationships with age, sex, ethnicity, and socioeconomic deprivation.

Authors:  Sarah-Jane Paine; Philippa H Gander; Ricci Harris; Papaarangi Reid
Journal:  Sleep       Date:  2004-09-15       Impact factor: 5.849

10.  Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.

Authors:  John W Winkelman; Laurel Finn; Terry Young
Journal:  Sleep Med       Date:  2006-06-05       Impact factor: 3.492

View more
  32 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Restless legs syndrome: relationship between prevalence and latitude.

Authors:  Brian B Koo
Journal:  Sleep Breath       Date:  2011-12-31       Impact factor: 2.816

3.  Sleep Disorders in Indigenous Communities: Time to Close the Gap.

Authors:  Garun Hamilton; Simon Joosten
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

4.  Prevalence of High Epworth Sleepiness Scale scores in a rural population.

Authors:  P Pahwa; C P Karunanayake; L Hagel; J A Gjevre; D Rennie; J Lawson; J A Dosman
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

Review 5.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

6.  Depressive Symptoms before and after Treatment of Obstructive Sleep Apnea in Men and Women.

Authors:  Cass Edwards; Sutapa Mukherjee; Laila Simpson; Lyle J Palmer; Osvaldo P Almeida; David R Hillman
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

7.  The prevalence of restless legs syndrome in Edirne and its districts concomitant comorbid conditions and secondary complications.

Authors:  Sibel Güler; Ayşe Caylan; F Nesrin Turan; Nezih Dağdeviren; Yahya Çelik
Journal:  Neurol Sci       Date:  2015-05-20       Impact factor: 3.307

8.  Prospective study of restless legs syndrome and risk of depression in women.

Authors:  Yanping Li; Fariba Mirzaei; Eilis J O'Reilly; John Winkelman; Atul Malhotra; Olivia Ifeoma Okereke; Alberto Ascherio; Xiang Gao
Journal:  Am J Epidemiol       Date:  2012-07-17       Impact factor: 4.897

9.  Excessive Daytime Sleepiness in Acute Ischemic Stroke: Association With Restless Legs Syndrome, Diabetes Mellitus, Obesity, and Sleep-Disordered Breathing.

Authors:  Pavel Šiarnik; Katarína Klobučníková; Pavol Šurda; Matúš Putala; Stanislav Šutovský; Branislav Kollár; Peter Turčáni
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

Review 10.  Obstructive sleep apnoea in adult indigenous populations in high-income countries: an integrative review.

Authors:  Cindy E Woods; Kim Usher; Graeme Paul Maguire
Journal:  Sleep Breath       Date:  2014-08-02       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.